Synergistic combination for treatment of viral-mediated...

Details Synergistic combination for treatment of viral-mediated... Synergistic combination for treatment of viral-mediated...

A - Human Necessities

61

K

A61K 38/21 (2006.01) A61K 31/13 (2006.01) A61K 31/365 (2006.01) A61K 31/4164 (2006.01) A61K 31/505 (2006.01) A61K 31/517 (2006.01) A61K 31/7052 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2362877

Flavivirus and rhabdovirus infections may be treated by administering an interferon such as interferon .alpha.2, interferon .alpha.8 or interferon .beta. and at least one compound selected from 5-membered cyclic nucleosides, mycophenolic compounds, imidazole derivatives, aminoadamantanes and 2, 4- diaminopyrimidines.

Les infections au flavivirus et au rhabdovirus peuvent être traitées en administrant un interféron tel que l'interféron .alpha.2, l'interféron .alpha.8, ou l'interféron .beta., et au moins un composé sélectionné parmi des nucléosides cycliques pentagonaux, des composés mycophénoliques, des dérivés d'imidazole, des aminoadamantanes et des 2, 4-diaminopyrimidines.

Affiliated with

Also associated with

Rating

Synergistic combination for treatment of viral-mediated... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Synergistic combination for treatment of viral-mediated..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Synergistic combination for treatment of viral-mediated... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1980820